Insider Buying: Amdocs (NASDAQ:DOX) Director Buys $100,800.00 in Stock

Amdocs Limited (NASDAQ:DOX – Get Free Report) Director Yvette Kanouff purchased 2,400 shares of the firm’s stock in a transaction dated Monday, November 9th. The shares were purchased at an average cost of $42.00 per share, for a total transaction of $100,800.00. Following the purchase, the director directly owned 26,600 shares in the company, valued at approximately $1,117,200. This represents a 9.92% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Amdocs Trading Up 1.5%

Shares of NASDAQ DOX traded up $0.68 during midday trading on Friday, reaching $44.79. 2,245,070 shares of the stock were exchanged, compared to its average volume of 2,150,916. The company has a market capitalization of $4.84 billion, a P/E ratio of 9.59, a P/E/G ratio of 1.44 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 52-week low of $39.96 and a 52-week high of $84.95. The stock has a 50 day moving average price of $57.51 and a 200-day moving average price of $60.98.

Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The technology company reported $1.98 EPS for the quarter, hitting analysts’ consensus estimates of $1.98. The company had revenue of $1.19 billion for the quarter, compared to the consensus estimate of $1.19 billion. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The company’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same period last year, the business posted $1.83 EPS. Equities research analysts expect that Amdocs Limited will post 5.82 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a dividend of $0.5690 per share. The ex-dividend date is Thursday, December 31st. This represents a $2.28 annualized dividend and a dividend yield of 5.1%. Amdocs’s dividend payout ratio is currently 48.82%.

Top Amdocs Stories

These are some of the DOX stories that stood out recently:

  • Positive Sentiment: Amdocs is seeking shareholder approval for a 3% quarterly dividend increase, which could bolster its appeal to income-focused investors. Dividend proposal
  • Neutral Sentiment: Call-option trading was unusually active, with 2,152 calls purchased—about 430% above the average daily volume. The activity may reflect bullish positioning, but options trading alone does not establish a lasting change in sentiment.
  • Negative Sentiment: Insider Shimie Hortig sold 8,997 shares across transactions on November 10 and 11, reducing his holdings. The sales may weigh on sentiment, though he retained a substantial position. SEC filing

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on DOX shares. Stifel Nicolaus cut their target price on Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a research report on Wednesday, November 4th. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Weiss Ratings raised Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 23rd. Oppenheimer lowered Amdocs from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 4th. Finally, Zacks Research lowered shares of Amdocs from a “hold” rating to a “strong sell” rating in a research report on Monday, November 9th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Amdocs has a consensus rating of “Hold” and an average target price of $69.00.

View Our Latest Report on DOX

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Royal Bank of Canada grew its holdings in shares of Amdocs by 14.9% during the 1st quarter. Royal Bank of Canada now owns 446,125 shares of the technology company’s stock valued at $29,114,000 after purchasing an additional 57,740 shares during the last quarter. Renaissance Technologies LLC raised its position in shares of Amdocs by 429.6% during the first quarter. Renaissance Technologies LLC now owns 291,800 shares of the technology company’s stock worth $19,043,000 after acquiring an additional 236,700 shares during the last quarter. Steel Grove Capital Advisors LLC acquired a new position in Amdocs in the third quarter valued at $2,229,000. TD Waterhouse Canada Inc. lifted its stake in shares of Amdocs by 14.1% in the 2nd quarter. TD Waterhouse Canada Inc. now owns 247,521 shares of the technology company’s stock valued at $12,682,000 after purchasing an additional 30,555 shares during the period. Finally, Bank of America Corp DE boosted its stake in Amdocs by 29.1% during the first quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company’s stock worth $82,375,000 after acquiring an additional 284,435 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

About Amdocs

(Get Free Report)

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.

Featured Articles

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.